From: Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor
Brain region
Baseline
Tariquidar pre-treatment
Striatum
0.00 ± 0.08
0.07 ± 0.09**
Hippocampus
−0.05 ± 0.05
0.07 ± 0.05*
Frontal cortex
0.04 ± 0.07
0.03 ± 0.04
Posterior cortex
0.00 ± 0.05